RFA
MACK

Reilly Financial Advisors’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Reilly Financial Advisors’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-25
Closed -$1K – 954
2016
Q3 		$1K Hold
25
– – ﹤0.01% 823
2016
Q2 		$1K Hold
25
– – ﹤0.01% 789
2016
Q1 		$2K Hold
25
– – ﹤0.01% 1091
2015
Q4 		$2K Hold
25
– – ﹤0.01% 1095
2015
Q3 		$2K Hold
25
– – ﹤0.01% 1155
2015
Q2 		$2K Hold
25
– – ﹤0.01% 1247
2015
Q1 		$2K Sell
25
-102
-80% -$8.68K ﹤0.01% 1197
2014
Q4 		$11K Hold
127
– – ﹤0.01% 499
2014
Q3 		$9K Buy
+127
New +$6.79K ﹤0.01% 550

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Reilly Financial Advisors's MACK Position: Q4 2016 in Review

Reilly Financial Advisors sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2016, closing a stake of 25 shares — an estimated $1K sold.

Reilly Financial Advisors first reported a position in MACK in Q3 2014 and held it in 9 quarters. The position peaked at $11K in Q4 2014. 136 funds tracked by Wall St. Rank hold MACK as of Q4 2016.

  • Reilly Financial Advisors reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Reilly Financial Advisors sold 25 Merrimack Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1K.
  • Reilly Financial Advisors first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2014 and held it in 9 quarters.
  • Reilly Financial Advisors's Merrimack Pharmaceuticals, Inc. position peaked at $11K in Q4 2014.
  • 136 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2016.

Based on Reilly Financial Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.